Search results
On National Historic Marker Day, meet the CNY man whose plaques celebrate history in 49 states
The Post-Standard· 6 days agoAn imposing physical stature and a charisma to match, you would not know it to look at the self-made...
Lawmakers honor popular Kansas City DJ following cancer death
KCTV 5 Kansas City· 2 days agoA popular Kansas City radio DJ is gone, but memories of his laughter and spirit live on through a...
Why Big Pharma Is Following Novartis' Lead In A $25 Billion Market
Investor's Business Daily· 7 days agoThat could be why the first generation of radiopharmaceuticals were flops, Seth, the Actinium CEO,...
Curis to Release First Quarter 2024 Financial Results and Hold Conference Call on May 7, 2024
Morningstar· 2 days agoCuris, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, today announced that the Company ...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 2 days agoReplay and MD Anderson announce FDA clearance of IND application for first-in-class PRAME-targeted T-Cell Receptor Natural Killer (TCR-NK) cell therapy for hematological malignancies Phase 1/2 study in patients with relapsed/refractory AML
Targeting specific protein regions offers a new treatment approach in medulloblastoma
Medical Xpress· 7 days agoThe findings are reported in Nature Communications. Previous research by St. Jude scientists and others has classified medulloblastoma into four distinct molecular groups: WNT and SHH—driven ...
Earnings call: AbbVie surpasses Q1 expectations, announces CEO transition By Investing.com
Investing.com· 3 days agoThe earnings call also marked a significant leadership transition, with CEO Rick Gonzalez announcing...
HC Wainwright Reiterates Buy Rating for Actinium Pharmaceuticals (NYSEAMERICAN:ATNM)
ETF DAILY NEWS· 1 day agoActinium Pharmaceuticals (NYSEAMERICAN:ATNM – Get Free Report)‘s stock had its “buy” rating reaffirmed by HC Wainwright in a research note issued to investors on Monday, Benzinga reports. They ...
Brokerages Set Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Price Target at $195.08
ETF DAILY NEWS· 1 day agoShares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the thirteen ratings firms that are currently covering the ...
Earnings call: AbbVie surpasses Q1 expectations, announces CEO transition
Investing.com· 3 days agoThe earnings call also marked a significant leadership transition, with CEO Rick Gonzalez announcing...
